buserelin has been researched along with Neoplasm Metastasis in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (66.67) | 18.7374 |
| 1990's | 10 (30.30) | 18.2507 |
| 2000's | 1 (3.03) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, FH; Klijn, JG | 1 |
| Bloom, SR; Dunlop, H; Griffin, S; Kerle, D; Williams, G | 1 |
| Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW | 1 |
| Alexieva-Figusch, J; Blankenstein, MA; Blonk-van der Wijst, J; de Jong, FH; Docter, R; Klijn, JG; Lamberts, SW | 1 |
| Adenauer, H; Fazekas, AT; Klioze, S; Koutsilieris, M; Stellos, A; Tolis, G; Yakabow, A | 1 |
| Baker, T; Docherty, A; Isenberg, D; Tickle, S; Wasan, H; Waxman, J | 1 |
| De Pauw, M; de Voogt, HJ; Klijn, JG; Schröder, FH; Studer, UE; Sylvester, R | 1 |
| Doré, JC; Fiet, J; Gô, AL; Ojasoo, T; Raynaud, JP | 1 |
| Carpano, S; Di Lauro, L; Lopez, M; Natali, M; Pignatti, F; Vici, P | 1 |
| Blamey, RW; Boccardo, F; Duchateau, L; Klijn, JG; Sylvester, R; Tominaga, T | 1 |
| Falkson, CI; Falkson, G; Falkson, HC | 1 |
| Höfler, H; Lax, S; Pummer, K; Radner, H; Wandschneider, G | 1 |
| Bono, A; Carneiro de Moura, JL; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, D; Robinson, M; Smith, P; Sylvester, R | 1 |
| Bastert, G; Jonat, W; Kaufmann, M; Maass, H; Schachner-Wünschmann, E | 1 |
| Broglia, L; Francesca, F; Maffezzini, M; Rigatti, P; Villa, E | 1 |
| De Pauw, M; Denis, L; Newling, DW; Robinson, MR; Sylvester, R | 1 |
| Elder, JS; Gibbons, RP | 1 |
| Billebaud, T; Costa, P; Dahan, R; Fiet, J; Grise, P; Husson, JM; Kuhn, JM; Louis, JF; Moulonguet, A; Navratil, H | 1 |
| Albrecht, M; Eiermann, W; Hilfrich, J; Jänicke, F; Jonat, W; Kaufmann, M; Kleeberg, U; Kreienberg, R; Schmid, H; Weitzel, HK | 1 |
| Abel, P; Cox, J; Farah, N; Fleming, J; Hewitt, G; O'Donoghue, EP; Sandow, J; Sikora, K; Waxman, J; Williams, G | 1 |
| Ehrenthal, W; Happ, J; Jacobi, GH; Spindler, HW; von Wallenberg, H; Wenderoth, UK | 1 |
| Debruyne, FM; Fernandez del Moral, P; Litjens, TT; Weil, EH | 1 |
| Kaufmann, M; Kiesel, L; Klinga, K; Schmid, H | 1 |
| Adenis, L; Audhuy, B; Bugat, R; Colombel, P; Couette, JE; Grise, P; Khater, R; LePorz, B; Metz, R; Namer, M | 1 |
| Boulton, J; Croxson, MS; Harvey, V; Holdaway, IM; Ibbertson, HK; Knox, BS | 1 |
| Peeling, WB; Ryan, PG | 1 |
| Blackledge, GR; Emtage, LA; Hilton, C; Kelly, K; Trethowan, C | 1 |
| Alioth, H; Müller, J; Senn, E | 1 |
| Béland, G; Elhilali, M; Fradet, Y; Laroche, B; Ramsey, EW; Trachtenberg, J; Venner, PM | 1 |
| Paulson, DF | 1 |
| de Jong, FH; de Voogt, HJ; Debruyne, FM; Karthaus, HF; Klijn, JG; Schröder, FH | 1 |
| Hendry, WF; Oliver, RT; Waxman, JH; Whitfield, HN | 1 |
| Becher, R; Höffken, K; Miller, AA; Miller, B; Schmidt, CG | 1 |
3 review(s) available for buserelin and Neoplasm Metastasis
| Article | Year |
|---|---|
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Premenopause; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 2001 |
[LHRH agonists combined with antiandrogens in the treatment of metastasizing prostatic carcinoma].
Topics: Androgen Antagonists; Animals; Buserelin; Cyproterone; Cyproterone Acetate; Dogs; Drug Therapy, Combination; Flutamide; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Rats; Receptors, Cell Surface; Receptors, LHRH | 1985 |
[Hormone therapy of metastatic breast carcinoma].
Topics: Aminoglutethimide; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Menopause; Neoplasm Metastasis | 1985 |
13 trial(s) available for buserelin and Neoplasm Metastasis
| Article | Year |
|---|---|
Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer.
Topics: Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Short-term versus long-term addition of cyproterone acetate to buserelin therapy in comparison with orchidectomy in the treatment of metastatic prostate cancer. European Organization for Research and Treatment of Cancer--Genitourinary Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone Acetate; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms | 1993 |
Multivariate analysis of plasma hormones in patients with metastatic prostate cancer receiving combined LHRH-analog and antiandrogen therapy.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Buserelin; Double-Blind Method; Hormones; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Prostatic Neoplasms | 1993 |
Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Delayed-Action Preparations; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Ovary | 1992 |
Total androgen ablation: European experience. The EORTC GU Group.
Topics: Aged; Buserelin; Flutamide; Goserelin; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms | 1991 |
The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group.
Topics: Adult; Breast Neoplasms; Buserelin; Combined Modality Therapy; Delayed-Action Preparations; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Middle Aged; Neoplasm Metastasis | 1991 |
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Drug Evaluation; Humans; Imidazoles; Imidazolidines; Male; Multicenter Studies as Topic; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1989 |
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Injections, Subcutaneous; Menopause; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Remission Induction | 1989 |
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogue.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Flutamide; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; Random Allocation; Testosterone | 1988 |
Zoladex as primary therapy in advanced prostatic cancer. A French cooperative trial.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Follicle Stimulating Hormone; France; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prospective Studies; Prostate; Prostatic Neoplasms | 1988 |
U.K. trials of treatment for M1 prostatic cancer. The LH-RH analogue Zoladex vs. orchidectomy.
Topics: Aged; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Remission Induction; Testosterone; United Kingdom | 1988 |
Interim report of a randomized trial comparing Zoladex 3.6 mg depot with diethylstilbestrol 3 mg/day in advanced prostate cancer. The West Midlands Urology Research Group.
Topics: Buserelin; Delayed-Action Preparations; Diethylstilbestrol; England; Follow-Up Studies; Goserelin; Humans; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Random Allocation; Remission Induction; Testosterone | 1988 |
Total androgen blockade for metastatic cancer of the prostate.
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Combined Modality Therapy; Double-Blind Method; Humans; Imidazoles; Imidazolidines; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Placebos; Prognosis; Prostatic Neoplasms; Random Allocation; Remission Induction | 1988 |
17 other study(ies) available for buserelin and Neoplasm Metastasis
| Article | Year |
|---|---|
Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer.
Topics: Adult; Anovulation; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasm Metastasis | 1982 |
Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.
Topics: Buserelin; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1984 |
LHRH-agonist treatment in metastatic prostate carcinoma.
Topics: Aged; Alkaline Phosphatase; Bone Neoplasms; Buserelin; Drug Evaluation; Humans; Male; Neoplasm Metastasis; Prostate; Prostatic Neoplasms; Testosterone; Time Factors | 1984 |
Metastatic prostate cancer: hormone dependency and therapeutic efficacy of GnRH analogues.
Topics: Buserelin; Castration; Combined Modality Therapy; Humans; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms | 1984 |
Serum metalloproteinases and their inhibitors: markers for malignant potential.
Topics: Arthritis, Rheumatoid; Biomarkers, Tumor; Buserelin; Collagenases; Enzyme-Linked Immunosorbent Assay; Glycoproteins; Humans; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Metalloendopeptidases; Neoplasm Metastasis; Predictive Value of Tests; Prostatic Neoplasms; Proteins; Reference Values; Reproducibility of Results; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinases | 1994 |
Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyproterone; Drug Administration Schedule; Humans; Male; Middle Aged; Neoplasm Metastasis; Treatment Outcome | 1993 |
Pituitary hyperplasia after goserelin (LHRH-analogue) therapy.
Topics: Adrenocorticotropic Hormone; Aged; Buserelin; Goserelin; Growth Hormone; Humans; Hyperplasia; Immunohistochemistry; Male; Neoplasm Metastasis; Orchiectomy; Pituitary Gland, Anterior; Prostatic Neoplasms | 1991 |
Long-term results with the Gn-RH analogue, buserelin, in metastatic prostate cancer.
Topics: Aged; Buserelin; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1990 |
EORTC protocol 30853: orchidectomy versus zoladex plus flutamide in the management of metastatic carcinoma of the prostate. Interim statistical analysis of the side effects of treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Goserelin; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms | 1990 |
Advances in the treatment of metastatic prostatic cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Diethylstilbestrol; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Male; Neoplasm Metastasis; Orchiectomy; Palliative Care; Prostatic Neoplasms | 1985 |
Metastatic prostate cancer under long term pernasal buserelin or intramuscular decapeptyl depot treatment.
Topics: Administration, Intranasal; Antineoplastic Agents; Biomarkers, Tumor; Buserelin; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Male; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1987 |
Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer?
Topics: Aged; Buserelin; Diethylstilbestrol; Drug Evaluation; Drug Therapy, Combination; Goserelin; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1988 |
[Therapy with gonadotropin releasing hormone agonists (zoladex) in premenopausal females with metastastic breast cancer].
Topics: Adult; Breast Neoplasms; Buserelin; Female; Follow-Up Studies; Gonadal Steroid Hormones; Goserelin; Humans; Injections, Subcutaneous; Middle Aged; Neoplasm Metastasis | 1988 |
Zoladex treatment of symptomatic prostatic carcinoma.
Topics: Buserelin; Carcinoma; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction; Testosterone | 1988 |
Management of metastatic prostatic cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Castration; Cyclophosphamide; Diethylstilbestrol; Estramustine; Gonadotropin-Releasing Hormone; Hormones; Humans; Leuprolide; Male; Neoplasm Metastasis; Prostatic Neoplasms | 1985 |
Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer.
Topics: Acid Phosphatase; Aged; Buserelin; Drug Evaluation; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1985 |
A long term follow-up of patients with advanced prostatic cancer treated with buserelin.
Topics: Buserelin; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Time Factors | 1985 |